<DOC>
	<DOCNO>NCT02469948</DOCNO>
	<brief_summary>Stroke may result low extremity spasticity , interfere motor voluntary function activity daily live . Botulinum toxin type A ( BTX-A ) show improve low extremity spasticity stroke patient . There research compare efficiency BTX-A injection different guidance method deep muscle low extremity stroke patient . The aim investigator 's study compare effectiveness BTX-A injection different guidance method ( palpation anatomical landmark , ultrasonography direct ) deep spastic muscle low extremity stroke patient varus spasticity spastic claw toe , study correlation muscle spasticity elastic property sonoelastography/acoustic radiation force impulse imaging follow change elastic property spastic muscle BTX-A injection . We enroll 80 hemiplegic stroke patient varus spasticity / spastic claw toe duration 6 month . Under different guidance method ( palpation anatomical landmark , electric stimulation , ultrasonography direct indirect method ) , BTX-A inject flexor digitorum longus posterior tibialis muscle . If patient moderate hallucis spasticity , flexor hallucis longus muscle inject . The BTX-A dose 50 unit muscle . Outcome measure include Modified Ashworth Scale , Brunnstrom stage , muscle power , range motion , visual analog scale pain , Stroke Impact Scale , Barthel index lower extremity function test , balance test , Goal Attainment Scale , sonoelastography acoustic radiation force impulse imaging . All assessment perform BTX-A injection follow 1 month , 2 month , 3 month 6 month injection . After perform assessment , investigator investigate efficiency BTX-A different guidance method .</brief_summary>
	<brief_title>Botulinim Toxin Type A Injections Different Guidance Stroke Patients With Spasticity Lower Extremities</brief_title>
	<detailed_description>Stroke may result low extremity spasticity , interfere motor voluntary function activity daily live . Botulinum toxin type A ( BTX-A ) show improve low extremity spasticity stroke patient . There research compare efficiency BTX-A injection different guidance method deep muscle low extremity stroke patient . The aim investigator 's study compare effectiveness BTX-A injection different guidance method ( palpation anatomical landmark , electric stimulation , ultrasonography direct indirect method ) deep spastic muscle low extremity stroke patient varus spasticity spastic claw toe , study correlation muscle spasticity elastic property sonoelastography/acoustic radiation force impulse imaging follow change elastic property spastic muscle BTX-A injection . We enroll 80 hemiplegic stroke patient varus spasticity / spastic claw toe duration 6 month . Under different guidance method ( palpation anatomical landmark , electric stimulation , ultrasonography direct indirect method ) , BTX-A inject flexor digitorum longus posterior tibialis muscle . If patient moderate hallucis spasticity , flexor hallucis longus muscle inject . The BTX-A dose 50 unit muscle . Outcome measure include Modified Ashworth Scale , Brunnstrom stage , muscle power , range motion , visual analog scale pain , Stroke Impact Scale , Barthel index lower extremity function test , balance test , Goal Attainment Scale , sonoelastography acoustic radiation force impulse imaging . All assessment perform BTX-A injection follow 1 month , 2 month , 3 month 6 month injection . After perform assessment , investigator investigate efficiency BTX-A different guidance method . Two arm : 1. ultrasonography direct-guidance : To inject Botulinum toxin type A spasticity low extremity stroke patient Ultrasonography direct-guidance . 2. surface anatomy landmark : To inject Botulinum toxin type A spasticity low extremity stroke patient surface anatomy landmark .</detailed_description>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>ankle varus spasticity spasticity claw toe MP joint IP joint Modified Ashworth Scale 1 + ankle varus spasticity spasticity claw toe walk reach median level patient feel pain uncomfortable walk due spasticity claw toe . patient never accept botox , phenol alcohol injection . contracture deformity low extremity combine systemic disease neurological skelectomuscular system patient accept botox , phenol , alcohol injection operation . cognition disorder aphasia stroke Flexor Digitorum Longus , posterior tibialis Flexor pollicis longus muscle significant atrophy . systemic infection medication treatment aminioglycoside change neuromuskular transmission medicine ankle plantarflxeor contracture walk median level sore Modified Ashworth Scale 2 rest allergy botox</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>spasticity</keyword>
	<keyword>botulinum toxin</keyword>
	<keyword>ultrasonography guidance</keyword>
	<keyword>electric stimulation guidance</keyword>
	<keyword>stroke</keyword>
</DOC>